Skip to main content

ORIGINAL RESEARCH article

Front. Oncol.
Sec. Surgical Oncology
Volume 14 - 2024 | doi: 10.3389/fonc.2024.1387611
This article is part of the Research Topic Multimodal Treatment of Oligometastatic Esophagogastric Cancer: State of the Art and Future Perspectives View all 3 articles

Clinicopathologic Features and Surgical Treatment Prognosis of Esophageal Carcinosarcoma

Provisionally accepted
Jiangfeng Shen Jiangfeng Shen Kaijin Lu Kaijin Lu Fuxing Liu Fuxing Liu Xia Chen Xia Chen Quan Chen Quan Chen Bingbing Wu Bingbing Wu Hailan Wang Hailan Wang Pengfei Ge Pengfei Ge Guang Han Guang Han Fei Wang Fei Wang Peng Zhang Peng Zhang Pei Yin Pei Yin Weiguang Jia Weiguang Jia Yiming Zheng Yiming Zheng Pengcheng Wang Pengcheng Wang Fei Sun Fei Sun *
  • The Affiliated Taizhou People's Hospital, Nanjing Medical University, Taizhou, China

The final, formatted version of the article will be published soon.

    Carcinosarcoma is a rare esophageal tumor, accounting for approximately 0.27-2.8% of malignant esophageal tumors. Out of the 1261 patients who underwent surgical treatment for esophageal cancer, 16 cases were pathologically confirmed as carcinosarcoma. Among them, two underwent neoadjuvant chemotherapy, six received postoperative chemotherapy, one underwent exclusive radiotherapy postoperatively, and two received a combination of postoperative chemotherapy and radiotherapy. Carcinosarcomas predominantly occurred in the middle (43.75%) and lower (50%) segments of the esophagus. Microscopic examination revealed coexistence and transitional transitions between sarcomatous and carcinoma components. Among the 16 patients, 15 (93.75%) were positive for vimentin, 11 (68.75%) for CKpan, 13 (81.25%) for CK5/6, and 13 (81.25%) for p53. Pathological staging showed 5 cases in stage T1, 2 in stage T2, and 9 in stage T3, with lymph node metastasis observed in 6 cases (37.5%). TNM staging revealed 3 cases in stage I, 9 in stage II, and 4 in stage III. The overall 1, 3, and 5-year survival rates were 86.67%, 62.5%, and 57.14%, respectively. Univariate analysis indicated that pathological N staging influenced survival rates, while multivariate analysis demonstrated that pathological N staging was an independent prognostic factor. Complete surgical

    Keywords: esophageal cancer, Carcinosarcoma, CLINICAL PATHOLOGY, surgical treatment, Prognosis analysis

    Received: 18 Feb 2024; Accepted: 31 Jul 2024.

    Copyright: © 2024 Shen, Lu, Liu, Chen, Chen, Wu, Wang, Ge, Han, Wang, Zhang, Yin, Jia, Zheng, Wang and Sun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Fei Sun, The Affiliated Taizhou People's Hospital, Nanjing Medical University, Taizhou, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.